Kim, E.S.; Lee, M.S.; Jeong, H.; Lim, S.Y.; Kim, D.; Kim, D.; Jung, J.; Lyu, S.; Cho, H.J.; Kim, D.M.;
et al. Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization. Pharmaceutics 2021, 13, 1548.
https://doi.org/10.3390/pharmaceutics13101548
AMA Style
Kim ES, Lee MS, Jeong H, Lim SY, Kim D, Kim D, Jung J, Lyu S, Cho HJ, Kim DM,
et al. Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization. Pharmaceutics. 2021; 13(10):1548.
https://doi.org/10.3390/pharmaceutics13101548
Chicago/Turabian Style
Kim, E Seul, Min Sang Lee, Hayoung Jeong, Su Yeon Lim, Doha Kim, Dahwun Kim, Jaeback Jung, Siyan Lyu, Hee Joo Cho, Dong Min Kim,
and et al. 2021. "Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization" Pharmaceutics 13, no. 10: 1548.
https://doi.org/10.3390/pharmaceutics13101548
APA Style
Kim, E. S., Lee, M. S., Jeong, H., Lim, S. Y., Kim, D., Kim, D., Jung, J., Lyu, S., Cho, H. J., Kim, D. M., Suh, W., & Jeong, J. H.
(2021). Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization. Pharmaceutics, 13(10), 1548.
https://doi.org/10.3390/pharmaceutics13101548